Takeaways: Rayner’s fully preloaded RayOne Aspheric IOL has received NMPA approval for sale in China. RayOne Aspheric will be showcased at the 21st CSCRS from 3-5 June 2021 in Dalian. RayOne Aspheric offers a premium alternative to Rayner’s C-flex/Superflex Aspheric monofocal IOLs. Rayner’s award-winning RayOne IOL platform has been used in over 1.6 million procedures since 2016. Rayner will next

Rayner, manufacturer of the world’s first IOL designed by Sir Harold Ridley, announced today that the US Food and Drugs Administration (FDA) have approved the RayOne Aspheric fully preloaded IOL injection system for use in the United States of America. Product approval details The FDA granted regulatory approval and sale of the RayOne Aspheric Monofocal

Rayner set to launch 600C monofocal aspheric IOL at ASCRS

Rayner has announced the launch of the 600C Aspheric IOL. The 600C Aspheric IOL will be unveiled at the upcoming 2018 ASCRS conference in Washington, DC, 13-17 A...

FDA approval expands US access to award-winning lens technology Rayner today announced that the US Food and Drug Administration (FDA) has approved its RayOne EMV Toric intraocular lens (IOL) following the successful completion of a pivotal Investigational Device Exemption (IDE) study. The lens is now available to US surgeons seeking to deliver high quality visual

Mississauga, ON | 21 January 2025 Rayner, a global manufacturer of products for cataract surgery based in Worthing, UK, is pleased to announce the approval of RayOne EMV Toric (RAO210T) by Health Canada. Developed in collaboration with Professor Graham Barrett, RayOne EMV and RayOne EMV Toric are the only patented aspheric IOLs that induce controlled

Rayner, a global manufacturer of products for cataract surgery based in Worthing, UK, proudly announces delivery of its 5 millionth RayOne lens (and 11 millionth lens made from RayAcryl Rayner’s proprietary hydrophilic acrylic material), marking an important milestone in units sold globally. RayOne is Rayner’s fully-preloaded intraocular lens (IOL) injection system, providing smooth, consistent rolling

Mississauga, ON, 23 January 2024 Rayner, a global leader in products for cataract surgery, proudly announces the approval of RayOne EMV (RAO200E) by Health Canada1. Developed in collaboration with Professor Graham Barrett, RayOne EMV is the only patented aspheric IOL that induces controlled positive spherical aberration to slightly extend the depth of focus. “I’ve been awaiting

JANUARY 05, 2022 – Worthing, United Kingdom. Rayner, the only UK manufacturer of intraocular lenses (IOLs), today announced the launch of RayOne Hydrophobic BLF. Made of its proprietary ultra glistening-free hydrophobic material, RayOne Hydrophobic BLF is Rayner’s first blue light filtering IOL. RayOne Hydrophobic BLF expands Rayner’s RayOne lens portfolio from seven to eight variants, now with

NOVEMBER 24, 2021 – Worthing, United Kingdom. Rayner, a leading ophthalmology company focused on optimising visual outcomes for patients and surgeons, today announced the appointment of Dr Rob Nadler to the role of VP Corporate Development. Dr Nadler will play a critical role on the executive team, overseeing the company’s M&A strategy and brings invaluable clinical,

New York, USA, May 17, 2021 – RayOne Spheric, a fully-preloaded monofocal IOL, has received FDA approval. This achievement marks Rayner’s third FDA approval in under three years within its expanding RayOne preloaded IOL portfolio. RayOne Spheric joins RayOne Aspheric (FDA approved December 2018) and RayOne EMV, a new non-diffractive IOL solution which achieved FDA

Worthing, UK – Following the recent approval of incorporation, Rayner is proud to announce its direct entry into the Canadian ophthalmology market. Led by Wade Allen, Director: Americas, Rayner Surgical Corp will now be offering the Rayner portfolio of IOLs and injectors directly to Canadian surgeons. Rayner Surgical Corp has recently had the RayOne Aspheric

Rayner set to launch RayOne EMV in early October Worthing, UK, September 21st, 2020 – Rayner has announced the upcoming launch of RayOne EMV: a new fully preloaded non-diffractive IOL solution designed specifically to enhance patient outcomes achieved with monovision. Enhanced range of vision Developed in collaboration with Professor Graham Barrett, president of the Australasian

Rayner hosted its first surgeon clinical education webinar on 27 May 2020, with attendees from over 47 countries. Over the course of one hour, the three presenters spoke about returning to clinic (including associated safety precautions), their experience with premium trifocal IOLs, and the utilisation of contactless telehealth. The webinar was concluded with a busy

For Immediate Release Date: 7th August 2018 Rayner are proud to announce the launch of the new, CE marked Sulcoflex Trifocal Pseudophakic Supplementary IOL at the 2018 ESCRS in Vienna. Rayner’s most technologically advanced IOL The Sulcoflex Trifocal combines Rayner’s pseudophakic supplementary Sulcoflex platform — designed to be implanted in the ciliary sulcus and with over ten

Supporting paediatric cataract surgery in Ethiopia A visit by Dr Geoffrey Woodruff, Consultant Paediatric Ophthalmologist Emeritus, Leicester Royal Infirmary UK to Ethiopia 25th March to 3rd April 2018. Rayner is proud to have supplied Dr Woodruff with Rayner C-flex Aspheric Monofocal IOLs and OphteisBio 3 % OVD for his recent visit to Ethiopia as Visiting Professor & Mentor

RayOne Hydrophobic, Rayner’s first fully preloaded IOL system with a hydrophobic acrylic lens, is now available to CE Mark-accepting countries. Daily compromises faced by cataract surgeons are eliminated with a new proprietary material, unique Cornerstone lens shape and intuitive fully preloaded injector. Worthing (UK), May 22nd, 2018 – Rayner, the manufacturer of the world’s first IOL,

For immediate release. Date: 05 March, 2018. RayOne Fully Preloaded IOL injection system now available in Argentina Rayner, together with Iskowitz – Rayner’s exclusive distributor in Argentina — announced today that the RayOne fully preloaded IOL injection system has received approval from the Argentine regulator, ‘Administración Nacional de Medicamentos, Alimentos y Tecnología Médica’ (ANMAT), and is now

For immediate release Ten year milestones achieved for key Primary & Supplementary IOLs. 2017 in review. 18th January, 2018. Worthing, United Kingdom. Over the course of 2017, Rayner marked the ten year anniversary for receiving CE approval for the following IOLs: Sulcoflex Aspheric C-flex Aspheric Superflex Aspheric M-flex T Multifocal Toric Milestone one: Sulcoflex Aspheric Supplementary IOL: A solution to

For immediate release. Date: 17 October, 2017. Surgeons in India to access RayOne fully preloaded IOL injection system. British IOL manufacturer, Rayner, announced today that their new RayOne fully preloaded IOL injection system has received Central Drugs Standard Organisation (CDSCO) approval and is being launched in India. Product approval details The CDSCO granted regulatory approval and sale

For immediate release. Date: 11 July, 2017. RayOne Fully Preloaded IOL Injection System. Now available in Brazil. More surgeons to access the smallest Fully Preloaded IOL Incision Rayner announced today the latest update in the RayOne story: registration of the RayOne Aspheric and Spheric monofocal fully preloaded IOL injection systems has been listed in the Federal Register

An experimental study was recently conducted to compare current fully preloaded intraocular lens (IOL) injection systems on the market. 

The study explored wound architecture after IOL implantation and the overall ease and speed...

For immediate release. Rayner marks ten years of C-flex in the USA 14 March 2017. Worthing, United Kingdom. Rayner announced today that it will mark an important milestone next month: the ten year anniversary of US Food and Drug Administration (FDA) approval of C-flex 570C monofocal Intraocular Lens (IOL) for commercial use in the United States of America.

For immediate release. March 02, 2017 – Worthing, United Kingdom. Rayner announced today that a selection of models in their Sulcoflex range of pseudophakic supplementary IOLs have received Chinese Food and Drug Administration (CFDA) approval and are to be launched in market in 2017. Rayner is the first manufacturer to make a supplementary IOL available to surgeons in

Phoenix Equity Partners ("Phoenix"), a leading UK middle-market private equity firm, today announces an investment in Rayner Surgical Group (“Rayner” or “the Company”) alongside the current management team...

The new-look Rayner booth -- designed specifically with RayOne^® demos in mind -- was inundated with traffic. Surgeons clamored to experience the highly anticipated, fully preloaded IOL injection system at the recent XXXIV Congres...

For immediate release. Date: 1st September, 2016 The Smallest Fully Preloaded IOL Incision. Rayner set to launch RayOne at the Upcoming ESCRS Following the recent receipt of CE mark approval, Rayner are proud to announce the launch of RayOne: their fully preloaded IOL injection system to be unveiled at the upcoming ESCRS in Copenhagen. This flagship launch is

Rayner’s growth strategy continues as the company announced today that the Egyptian Ministry of Health has approved the following IOLs for sale in Egypt: C-flex Aspheric monofocal IOL range (970C) Superflex Aspheric monofocal IOL range (920H) T-flex Aspheric Toric IOL (573T and 623T) Sulcoflex Pseudophakic Supplementary Aspheric IOL (653L)  Rayner’s unique system package means that in addition to an

Highlights and valuable insights from Professor Rudy Nuijts and Peers now available for download   Professor Rudy Nuijts, Professor Mats Lundstrӧm, Professor James Wolffsohn, Professor Michael Amon, Mr Allon Barsam and Dr Tiago Ferreira made up the panel of presenters for the Symposium ‘Refractive Surprise; The Big Taboo’ — an education program sponsored by Rayner

The 2015 meeting of the European Society of Cataract and Refractive Surgeons (ESCRS) held in Barcelona, Spain, featured a number of presentations describing surgeons’ experience with Rayner’s portfolio of lenses including the Sulcoflex, C-flex, M-flex and T-flex. The Sulcoflex Pseudophakic Supplementary IOL Supplementary IOLs Versus Wavefront-Guided LASIK for the Correction of Refractive ErrorsTiago Ferreira, MDDr Ferreira described

Professor Oliver Findl, Dr Nino Hirnschall and Professor Michael Amon hosted Rayner’s recent DFP-certified Premium IOL Wetlab event in Vienna, Austria in September 2015. The group of enthusiastic junior surgeons were exposed to a full Toric and Supplementary (Sulcoflex) program which consisted of the following key topics: • Introduction to astigmatism correction • The history of astigmatism correction •

At the 2015 meeting of the European Society of Cataract and Refractive Surgeons Rayner hosted a Satellite Symposium featuring the topic of refractive surprise. The session was introduced and moderated by Prof. Rudy Nuijts, who highlighted that refractive surprise is a serious challenge in cataract and refractive surgery and requires further thought for management. The